Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H1N1 immunogenicity study of Focetria
NL-OMON32857Phase 4Active, not recruiting
- Sponsor
- Elisabeth-TweeSteden Ziekenhuis
- Start
- Nov 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Influenza A infection, sponsored by Elisabeth-TweeSteden Ziekenhuis. Primary endpoints: Humoral immune response, Cellular immune response and 4 more. Started Nov 2009; status: active, not recruiting.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on NL-OMON32857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32857.